<DOC>
	<DOCNO>NCT02412098</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics ( PK ) , safety , tolerability single oral dose eleclazine participant normal impaired hepatic function . Participants healthy control group match participant impaired hepatic function age ( ± 5 year ) , gender , body mass index ( ± 10 % ) .</brief_summary>
	<brief_title>Pharmacokinetics Eleclazine Adults With Normal Impaired Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Long QT Syndrome</mesh_term>
	<criteria>All participant : Be nonsmoker consume &lt; 20 cigarette per day Have calculate body mass index ( BMI ) 18 36 kg/m^2 , inclusive , study screen Have creatinine clearance ( CrCl ) ≥ 60 mL/min ( use CockcroftGault method ) base serum creatinine actual body weight measure screen Have either normal 12lead electrocardiogram ( ECG ) one abnormality consider clinically insignificant investigator Screening lab within define threshold Participants mild , moderate , severe hepatic impairment must also meet follow additional inclusion criterion : Must diagnosis chronic ( &gt; 6 month ) , stable hepatic impairment clinically significant change within 3 month ( 90 day ) prior study drug administration ( Day 1 ) Individuals severe hepatic impairment must score ChildPughTurcotte scale 1015 screening . If individual 's score change course study , score screening use classification . Individuals moderate hepatic impairment must score ChildPughTurcotte scale 79 screening . If individual 's score change course study , score Screening use classification . Individuals mild hepatic impairment must score ChildPughTurcotte scale 56 screening . If individual 's score change course study , score screening use classification . Pregnant lactating female History meningitis encephalitis , epilepsy , seizure , migraine , tremor , myoclonic jerk , narcolepsy , obstructive sleep apnea , anxiety , syncope , head injury family history seizure Presence history cardiovascular disease ( include history myocardial infarction base ECG and/or clinical history , history ventricular tachycardia , congestive heart failure , cardiomyopathy , leave ventricular ejection fraction &lt; 40 % ) , cardiac conduction abnormality , family history Long QT Syndrome , unexplained death otherwise healthy individual age 1 30 year Syncope , palpitation , unexplained dizziness Implanted defibrillator pacemaker Are unable comply study requirement otherwise believe , study investigator , inappropriate study participation reason Active hepatitis B virus ( HBV ) infection . Individuals HBsAg ineligible Requires paracentesis &gt; 1 time per month Severe ( grade 3 4 ) encephalopathy judge investigator History gastric esophageal variceal bleed within past 6 month varix adequately treat medication and/or surgical procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hepatic Impairment</keyword>
</DOC>